CHOCTAW GENERAL HOSPITAL — History
CCN 011304 | 3-year financial timeline | COVID resilience: 78/100
🛡️ Public data only — no PHI permitted on this instance.
$18M
Latest Revenue (FY2022)
+8.3%
Revenue CAGR (3yr)
-2.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $17M | $18M | +1.7% | +8.3% |
| Operating Expenses | $18M | $19M | $18M | -5.0% | +0.2% |
| Operating Margin | -20.0% | -10.0% | -2.8% | +72.4% | +0.0% |
| Net Income | $-3M | $-2M | $-0M | +71.9% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 1,774 | 1,605 | 1,965 | +22.4% | +5.2% |
| Medicare Day % | 65% | 68% | 58% | -14.9% | -5.1% |
| Medicaid Day % | 1% | 1% | 0% | -65.0% | -32.8% |
COVID Impact & Recovery
Resilience Score: 78/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +17.3% ($15M → $18M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.3%
This Hospital
+7.6%
State Avg
Latest Margin
-2.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $19M | 5.9% |
| FY2024 (proj) | $20M | 14.5% |
| FY2025 (proj) | $22M | 23.1% |